| Study |
Aim of Comparison |
Comparing Group |
HVLT performance |
Significance |
| IR |
DR |
| Lacritz et al. [42] |
HVLT-R VS CVLT |
HVLT |
26.3 (4.9) |
10.2 (1.8) |
IR: r=0.74, p<0.001; DR: r=0.65, p<0.001 |
| CVLT |
50.2 (9.7) |
11.9 (2.5) |
| Shapiro et al. [7] |
NCI VS AD |
NCI |
24.8 (5.1) |
- |
F=164.8, p<0.001 |
| |
AD |
12.2 (5.3) |
- |
| NCI VS VaD |
NCI |
24.6 (5.5) |
- |
F=56.4, P<0.001 |
| |
VaD |
14.5 (5.8) |
- |
| Lacritz et al. [34] |
HVLT-R VS CVLT |
HVLT |
11.4 (3.5) |
0.6 (1.3) |
IR: r=0.36, p=0.02; DR: r=0.62, p<0.001 |
| CVLT |
19.2 (6.9) |
1.2 (2.0) |
| Gaines et al. [43] |
NCI VS Dementia |
NCI |
25.3 (4.9) |
8.9 (2.1) |
p<0.05 |
| VaD |
15.1 (4.8) |
2.9 (2.5) |
| AD |
12.2 (4.8) |
1.3 (1.5) |
| Foster et al. [40] |
NCI VS Mild AD VS mod AD |
NCI |
26.0 (9.6) |
4.4 (2.2) |
IR: F=54.47, p<0.0001 |
| mild AD |
14.0 (1.5) |
4.7 (2.5) |
| moderate AD |
8.8 (1.0) |
1.0 (2.1) |
| Baek et al. [32] |
NCI VS MCI VS AD |
NCI |
20.6 (4.3) |
6.4 (2.1) |
IR: F=66.12, p<0.001; DR: F=81.6, P<0.001 |
| MCI |
16.3 (4.3) |
3.4 (2.5) |
| AD |
12.4 (4.1) |
1.4 (2.1) |
| McLaughlin et al. [44] |
DLB VS AD |
DLB |
2.5 (1.8) |
1.2 (2.0) |
IR: p<0.04; DR: p=0.01 |
| AD |
1.6 (1.1) |
0.0 (0.3) |
| Gómez-Tortosa et al. [38] |
Baseline |
MCI (DI<8) |
15.4 (3.0) |
2.3 (1.9) |
IR: p<0.001; DR: p<0.0001 |
| MCI (DI>=8) |
16.8 (3.0) |
3.5 (1.9) |
| 48 ±12 Months follow-up |
MCI (stable) |
16.7 (3.0) |
3.6 (1.8) |
IR: p=0.001; DR: p<0.0001 |
| MCI (progression) |
15.2 (3.1) |
1.8 (1.9) |
|
